Logo

American Heart Association

  2
  0


Final ID: Sa1122

Association Between Imaging Follow Up and 1-Year Reintervention Risk After Peripheral Vascular Intervention for Claudicatio

Abstract Body (Do not enter title and authors here): Background: One-third of patients undergoing peripheral vascular intervention (PVI) for refractory claudication undergo a reintervention within 1 year. It is unknown whether receiving follow up imaging after PVI for claudication is associated with 1-year reintervention risk.
Aim: To assess the association between receiving imaging follow-up within 3 months after PVI for claudication and 1-year reintervention risk before occurrence of major amputation.
Method: We studied patients with claudication undergoing PVI who were alive and without reintervention at 3 months (2015-2018) in the Vascular Quality registry. Reintervention and imaging data were defined from Medicare data. Imaging follow-up included ankle brachial index (ABI), duplex ultrasound (DU), computed tomography angiography (CTA), and magnetic resonance angiogram (MRA) within 3 months post-PVI. We propensity-matched 1:1 for imaging follow-up status (No vs. Yes). The Aalen-Johansen method and Fine-Gray model assessed the 1-year cumulative incidence and reintervention risk (sub-hazard ratio, sHR) in patients without vs. with imaging follow-up, accounting for the competing mortality risk. Sensitivity analysis excluded ABI from imaging follow-up.
Results: Each imaging follow-up status included 2,208 patients. Mean age was 71.3±8.4 years and 39.0% female. In patients with imaging, 47.1% received 1 imaging test, of which 75.1% were ABIs. Over 50% received ≥2 imaging tests within 3 months post-PVI, with 5% receiving ≥1 per month. The 1-year cumulative incidence and reintervention risk was similar in patients without vs. with imaging (17.5% 95%CI 15.9-19.2 vs. 18.8% 95%CI 17.1-19.2 and sHR 0.92 95%CI 0.80-1.06, P=0.259). When excluding ABI, the 1-year cumulative incidence and reintervention risk was lower in those without vs. with imaging (18.3% 95%CI 16.6-20.2 vs. 21.1% 95%CI 19.2-23.0 and sHR 0.86 95%CI 0.74-0.99, P=0.039) (Figure).
Conclusion: Although over half of patients received multiple imaging tests within 3 months post-PVI for claudication, extensive imaging beyond ABI follow-up, was not associated with reintervention risk, which remained high with 1-year rates around 20%. Future efforts should study optimal imaging strategies and cost-benefit ratios.
  • Romain, Gaelle  ( Yale University , New Haven , Connecticut , United States )
  • Smolderen, Kim  ( Yale University , New Haven , Connecticut , United States )
  • Cleman, Jacob  ( Yale University , New Haven , Connecticut , United States )
  • Callegari, Santiago  ( Yale University , New Haven , Connecticut , United States )
  • Rahman, Mufti  ( Yale University , New Haven , Connecticut , United States )
  • Knight, Derek  ( Yale University , New Haven , Connecticut , United States )
  • Mena-hurtado, Carlos  ( Yale University , New Haven , Connecticut , United States )
  • Author Disclosures:
    Gaelle Romain: DO NOT have relevant financial relationships | Kim Smolderen: DO have relevant financial relationships ; Consultant:Terumo:Active (exists now) ; Consultant:Happify:Active (exists now) ; Research Funding (PI or named investigator):Philips:Active (exists now) ; Research Funding (PI or named investigator):Merck:Active (exists now) ; Research Funding (PI or named investigator):Abbott:Active (exists now) ; Research Funding (PI or named investigator):J&J:Active (exists now) ; Consultant:Cook:Active (exists now) | Jacob Cleman: No Answer | Santiago Callegari: DO NOT have relevant financial relationships | Mufti Rahman: DO NOT have relevant financial relationships | Derek Knight: No Answer | Carlos Mena-Hurtado: DO have relevant financial relationships ; Consultant:Cook:Active (exists now) ; Research Funding (PI or named investigator):Merck :Active (exists now) ; Research Funding (PI or named investigator):Abbott:Active (exists now) ; Research Funding (PI or named investigator):Shockwave:Active (exists now) ; Consultant:BD:Active (exists now)
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

From Lungs to Toes, WAZE Around Peripheral Clots and Blocks

Saturday, 11/16/2024 , 02:00PM - 03:00PM

Abstract Poster Session

More abstracts from these authors:
Association Between Diabetes and 5-year Mortality and Major Amputation Outcomes After Revascularization in Chronic Limb-threatening Ischemia

Callegari Santiago, Cleman Jacob, Rahman Mufti, Aggarwal Abhinav, Smolderen Kim, Mena-hurtado Carlos, Romain Gaelle

Association Between Guideline-directed Medical Therapy and Reintervention Risk at 2 Years Following Peripheral Vascular Interventions

Callegari Santiago, Cleman Jacob, Rahman Mufti, Capuano Isabella, Smolderen Kim, Mena-hurtado Carlos, Romain Gaelle

You have to be authorized to contact abstract author. Please, Login
Not Available